Search - tctmd.com

Displaying 721 - 740 of 1334

Sort: Relevancy | Date

News Daily News

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

January 01, 2014

News Daily News

稳定型患者在停用氯吡格雷后未出现反弹效应

December 05, 2013

News Daily News

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

December 05, 2013

News Daily News

No Rebound Effect after Clopidogrel Cessation in Stable Patients

December 05, 2013

News Conference News AHA 2013

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Yael L. Maxwell

November 18, 2013

Presentation

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Presenter: Isobel Ford

November 12, 2013

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Daily News

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

L.A. McKeown

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

No, Clopidogrel Is Safer and Effective Enough for Many Patients!

Presenter: Jorge Saucedo

October 31, 2013

Presentation TCT 2013

Clopidogrel Is Cheap, Effective, and Sufficient for Most!

Presenter: Fausto Feres

October 31, 2013

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Presentation TCT 2013

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

Presenter: Thomas Stuckey

October 29, 2013

Presentation TCT 2013

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

Presenter: Lorenz Raber

October 29, 2013

Advertisement

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

稳定型患者在停用氯吡格雷后未出现反弹效应

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

No Rebound Effect after Clopidogrel Cessation in Stable Patients

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

No, Clopidogrel Is Safer and Effective Enough for Many Patients!

Clopidogrel Is Cheap, Effective, and Sufficient for Most!

Studies Find Differing Benefits of Platelet, Genotype Testing

OPTIMIZE: 3-Month DAPT Safe with ZES

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

TCT-4. Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content